FactCheck.org has found that Health Secretary Robert F. Kennedy Jr. made misleading comparisons when touting the speed of recent Food and Drug Administration drug approvals relative to prior administrations.
Investigators said Kennedy selectively cited approval time frames without accounting for differences in drug classes, emergency authorizations, pending applications and baseline statistics across comparable periods.
FactCheck.org reviewed FDA public data and historical averages, concluding that some recent approvals reflected continuity with trends established before the current administration took office. Other expedited decisions involved therapies that had already completed substantial review under prior leadership.
Kennedy’s statements appeared in public remarks promoting deregulatory goals and criticism of what he describes as bureaucratic delay in pharmaceutical oversight. FactCheck.org said accurate comparisons require matching drug categories and excluding outliers driven by pandemic-era emergency pathways.
The organization noted individual approval speed can vary widely based on clinical trial results, manufacturing inspections and priority designations unrelated to political transitions. Misleading aggregate claims risk distorting public understanding of regulatory performance.
FactCheck.org published its SciCheck analysis as Congress debated funding for health agencies and vaccine policy during Memorial Day week 2026.
Independent analysts said transparent FDA dashboards listing approval dates by therapeutic category remain the most reliable benchmark when evaluating political claims about regulatory pace.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.factcheck.org/scicheck/